Hepatic lipidosis associated with L-asparaginase treatment.
D000818:Animals; D001215:Asparaginase / Q000627:therapeutic use; D002849:Chromatography, Gas; D005227:Fatty Acids / Q000032:analysis; D005234:Fatty Liver / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007274:Injections, Intraperitoneal; D007938:Leukemia / Q000188:drug therapy; D008064:Lipidoses / Q000139:chemically induced*; D008297:Male; D008722:Methods; D051379:Mice; D014280:Triglycerides / Q000032:analysis
D005227:Fatty Acids; D014280:Triglycerides; D001215:Asparaginase